Jul 20, 2026
203:200
For every 200 shares held, investors received 203. The price per share adjusted from $49.90 to $49.16.
The split itself did not change the total investment value.
PET Pharm Biotech Co., Ltd. (TPEX:7762) operates in the Pharmaceuticals: major industry.
PET Pharm Biotech Co., Ltd. company overviewPET Pharm Biotech Co., Ltd.'s most recent stock split was on July 20, 2026. It was a 203-for-200 forward split, so shareholders received 203 shares for every 200 they held.
PET Pharm Biotech Co., Ltd. (TPEX:7762) has split its stock 4 times: a 316-for-313 split on December 17, 2024, a 258-for-253 split on June 24, 2025, a 151-for-149 split on August 25, 2025, and a 203-for-200 split on July 20, 2026.
PET Pharm Biotech Co., Ltd. has split its stock 4 times. This history records 4 forward splits between December 17, 2024 and July 20, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In PET Pharm Biotech Co., Ltd.'s 203-for-200 split on July 20, 2026, every 200 shares became 203 shares.
PET Pharm Biotech Co., Ltd. has not announced a new split in our records. Its most recent split was on July 20, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:7762 split will appear on this page.
Already premium?